ArticleJournal of virology2025
Dual regulatory role of hsa-miR-122b-5p in chikungunya virus infection via interaction with CHIKV 3'-UTR and HDAC4 modulation.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Establishment of a viral infection in the host involves complex interactions between the virus and the host. The present study was undertaken to evaluate one such interaction between a host microRNA (miRNA) with both the virus and its cellular target. Through a comprehensive high-throughput screen of a human miRNA mimics library, we identified that hsa-miR-122b-5p bound to chikungunya virus (CHIKV) 3'-untranslated region (3'-UTR), which we abrogated upon mutating the binding sites of the miRNA and determined that this miRNA regulated CHIKV infection. In-depth scrutiny of this miRNA's expression in CHIKV-susceptible host cells divulged that it was mainly expressed in macrophages, and temporal expression profiling analysis in these cells revealed that its expression negatively correlated to the virus infection. We further identified cellular targets of miR-122b-5p through global RNA seq analysis using antagomiRs, among which histone deacetylase 4 (HDAC4) displayed attributes that promoted CHIKV infection in macrophages. To dissect this phenomenon further, we performed loss-of-function assays using both miR-122b-5p and HDAC4 and observed regulation of pro-inflammatory cytokines, including the type I interferon system. Furthermore, miRNA mimics and antagomiR assays indicated that regulation of HDAC4 by miR-122b-5p may be associated with changes in the nuclear translocation of phosphorylated IRF3 during CHIKV infection. While this suggests a possible link, additional studies are needed to confirm this interaction and its underlying mechanism. Taken altogether, our study provides insights into the dual regulatory function of miR-122b-5p during CHIKV infection, highlighting its capacity to decrease viral titer by binding directly to the 3'UTR of the viral genome and its potential to promote nuclear translocation of phosphorylated IRF3, which may be indirectly influenced by modulation of its cellular target, HDAC4, thereby regulating host immune responses during CHIKV infection in macrophages. These findings may have significant implications for understanding the pathogenesis of CHIKV and for developing novel therapeutic strategies.IMPORTANCEHuman microRNAs (miRNAs) are central regulators of viral infection, acting through direct targeting of viral genomes or by modulating host cellular pathways. In this study, we demonstrate that miR-122b-5p plays a dual antiviral role during chikungunya virus (CHIKV) infection in macrophages-critical immune cells that serve as viral reservoirs. We show that miR-122b-5p directly binds to the 3' untranslated region of the CHIKV genome, thereby suppressing viral replication. Additionally, we uncover a previously uncharacterized mechanism in which miR-122b-5p modulates the host innate immune response by repressing HDAC4, a negative regulator of the type I interferon pathway. This repression may influence nuclear translocation of phosphorylated IRF3, potentially enhancing the antiviral transcriptional response. Our findings not only deepen our understanding of macrophage-intrinsic antiviral defenses against CHIKV but also highlight miR-122b-5p as a potential therapeutic target for enhancing host immunity and limiting viral propagation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.